Senior insider sale
Chief Scientific Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$39.2K
6.46K shares
What this filing means
ADLER ERIC plans to sell 6.46K shares of LEXEO THERAPEUTICS, INC. valued at approximately $39.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001959173-26-003716
Officer· Chief Scientific Officer
Since Nov 2023
6.46K
Shares to sell
$39.2K
Approx. market value
1.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/15/2026
1.59KTotal acquired1.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Vesting Compensation | 1.59K | — |
| Total | 1.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.87K
Market value
$31.1K
2/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.59K
Market value
$8.1K
5/18/2026
Total
Units
6.46K
Value
$39.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 4.87K | $31.1K | — | Completed |
| Planned — Approximate Date | ||||
5/18/2026 | 1.59K | $8.1K | NASDAQ | Planned |
| Total | 6.46K | $39.2K | ||